# ALBEMARLE CORP (ALB) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from ALBEMARLE CORP's 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/ALB/mda/fy2025/): filed 2026-02-11; accession 0000915913-26-000018 (https://www.sec.gov/Archives/edgar/data/915913/000091591326000018/alb-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/ALB/mda/fy2024/): filed 2025-02-12; accession 0000915913-25-000026 (https://www.sec.gov/Archives/edgar/data/915913/000091591325000026/alb-20241231.htm)
- [FY 2023 MD&A](/company/ALB/mda/fy2023/): filed 2024-02-15; accession 0000915913-24-000016 (https://www.sec.gov/Archives/edgar/data/915913/000091591324000016/alb-20231231.htm)
- [FY 2022 MD&A](/company/ALB/mda/fy2022/): filed 2023-02-15; accession 0000915913-23-000039 (https://www.sec.gov/Archives/edgar/data/915913/000091591323000039/alb-20221231.htm)
- [FY 2021 MD&A](/company/ALB/mda/fy2021/): filed 2022-02-22; accession 0000915913-22-000027 (https://www.sec.gov/Archives/edgar/data/915913/000091591322000027/alb-20211231.htm)

Back to /company/ALB/